Buscar
Precipio Inc
PRPOAñadir a la lista de seguimiento
23.970USD
+0.510+2.17%
Cierre 08-07 16:00（ET）Cotizaciones retrasadas 15 min
42.75MCap. mercado
PérdidaP/E TTM
Más Datos de Precipio Inc Compañía
Precipio, Inc. is a healthcare biotechnology company that is focused on cancer diagnostics. The Company’s technologies include HemeScreen and IV-Cell. The HemeScreen panels test for the presence of various mutations. In developing HemeScreen, it focused on improving the economics of providing blood cancer diagnostic tests and reducing laboratory technician time consumed in the testing process. Its technology enables testing to be completed in one rapid scanning process. IV-Cell is a cell culture media that addresses the problem of diagnostic mistakes through the process of selective culturing. IV-Cell is a universal media that enables simultaneous culturing of all four hematopoietic cell lineages. Its product category includes Molecular Kits and IV-Cell Cytogenetics Media. The Molecular Kits include Quantitative MPN Panel, ABL1 Resistance Panel, and others. The Company’s laboratory and research and development (R&D) facilities are located in New Haven, Connecticut and Omaha, Nebraska.
Perfil de Precipio Inc
Símbolo de cotizaciónPRPO
Nombre de la empresaPrecipio Inc
Fecha de salida a bolsaJul 18, 2000
Director ejecutivoDanieli (Ilan S)
Número de empleados54
Tipo de seguridadOrdinary Share
Fin del año fiscalJul 18
Dirección4 Science Park
CiudadNEW HAVEN
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal06511
Teléfono12037877888
Sitio Webhttps://www.precipiodx.com/
Símbolo de cotizaciónPRPO
Fecha de salida a bolsaJul 18, 2000
Director ejecutivoDanieli (Ilan S)
Ejecutivos de Precipio Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Ilan S. Danieli
Mr. Ilan S. Danieli
Chief Executive Officer, Founder, Director
Chief Executive Officer, Founder, Director
--
--
Dr. Jeffrey Cossman, M.D.
Dr. Jeffrey Cossman, M.D.
Independent Director
Independent Director
--
--
Mr. David S. Cohen
Mr. David S. Cohen
Independent Director
Independent Director
--
--
Ms. Kathleen D. Laporte
Ms. Kathleen D. Laporte
Independent Director
Independent Director
--
--
Dick Sandberg ,
Dick Sandberg ,
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Ahmed Zaki Sabet
Mr. Ahmed Zaki Sabet
Chief Operations Officer
Chief Operations Officer
--
--
Mr. Ronald A. (Ron) Andrews, Jr.
Mr. Ronald A. (Ron) Andrews, Jr.
Independent Director
Independent Director
--
--
Dr. Ayman A. Mohamed, M.D.
Dr. Ayman A. Mohamed, M.D.
Chief Technology Officer
Chief Technology Officer
--
--
Mr. Matthew Gage
Mr. Matthew Gage
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Christina R. Valauri
Ms. Christina R. Valauri
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Ilan S. Danieli
Mr. Ilan S. Danieli
Chief Executive Officer, Founder, Director
Chief Executive Officer, Founder, Director
--
--
Dr. Jeffrey Cossman, M.D.
Dr. Jeffrey Cossman, M.D.
Independent Director
Independent Director
--
--
Mr. David S. Cohen
Mr. David S. Cohen
Independent Director
Independent Director
--
--
Ms. Kathleen D. Laporte
Ms. Kathleen D. Laporte
Independent Director
Independent Director
--
--
Dick Sandberg ,
Dick Sandberg ,
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Ahmed Zaki Sabet
Mr. Ahmed Zaki Sabet
Chief Operations Officer
Chief Operations Officer
--
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Precipio Inc?
Los cinco principales accionistas de Precipio Inc son: Mr. Ilan S. Danieli
¿Cuántas instituciones poseen acciones de Precipio Inc (PRPO)?
A fecha de 2026Q1, 30 instituciones poseen acciones de Precipio Inc, con un valor de mercado combinado de aproximadamente 341.74K, lo que representa el 19.15% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -28788.00.
¿Cuál es la mayor fuente de ganancias de Precipio Inc?
El 2026Q1, el segmento empresarial Third party payers generó la ganancia más alta para Precipio Inc, ascendiendo a 11.70M y representando el 48.26% de la ganancia total.